Please see below for a list of search results.
Under the Human Tissue Act, the HTA has the power to issue its expected standards (or Directions) to establishments.
The GMC provides guidance setting out good practice principles for doctors involved in research.
Sands, the stillbirth and neonatal death charity, have developed model consent forms, information and guidance for health professionals seeking consent for post mortems on babies who have died before, during or shortly after birth.
The list provides guidance to the human application sector on which types of tissues and cells are regulated under the Human Tissue (Quality and Safety for Human Application) Regulations 2007 (as amended).
Clinicians and transplant teams are responsible for the overall care of donors and recipients, and for assessing the medical suitability of potential donors.
The HTA can provide an HTA licence for an emergency mortuary in the event of an incident.
The HTA has developed a system for doing this, working with the Home Office and other relevant bodies.
Licensed establishments are required to meet the standards that are detailed in the HTA’s assessment criteria.
This guide explains the requirements for licences which store tissues and cells for human application and for licences and/or third party agreements which carry out the procurement, testing, processing, distribution, import or export of tissues and cells for human application.
Read regulatory alert 002/2019
Notice for Designated Individuals in the Human Application sector and licence contacts in the Organ Donation and Transplantation sector regarding Dengue.
Issued 3 October 2019
The Regulations (PDF) were implemented on 5 July 2007 bringing the into UK law. The directive and it's subsequent updates are as follows: